| The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS T McDonnell, C Wincup, I Buchholz, C Pericleous, I Giles, V Ripoll, ... Blood reviews 39, 100610, 2020 | 123 | 2020 |
| Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus J Bakshi, BT Segura, C Wincup, A Rahman Clinical reviews in allergy & immunology 55 (3), 352-367, 2018 | 107 | 2018 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 90 | 2024 |
| Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort BT Segura, BS Bernstein, T McDonnell, C Wincup, V M Ripoll, I Giles, ... Rheumatology 59 (3), 524-533, 2020 | 69 | 2020 |
| Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians M Sloan, E Lever, R Harwood, C Gordon, C Wincup, M Blane, ... Rheumatology 61 (6), 2262-2274, 2022 | 63 | 2022 |
| Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic lupus erythematosus R Amarnani, SA Yeoh, EK Denneny, C Wincup Frontiers in medicine 7, 610257, 2021 | 63 | 2021 |
| Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach GA Robinson, J Peng, P Dönnes, L Coelewij, M Naja, A Radziszewska, ... The Lancet Rheumatology 2 (8), e485-e496, 2020 | 61 | 2020 |
| Medically explained symptoms: a mixed methods study of diagnostic, symptom and support experiences of patients with lupus and related systemic autoimmune diseases M Sloan, R Harwood, S Sutton, D D’Cruz, P Howard, C Wincup, ... Rheumatology Advances in Practice 4 (1), rkaa006, 2020 | 48 | 2020 |
| Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus C Wincup, M Menon, E Smith, A Schwartz, D Isenberg, EC Jury, C Mauri Annals of the rheumatic diseases 78 (8), 1140-1142, 2019 | 37 | 2019 |
| COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies A Gil‐Vila, N Ravichandran, A Selva‐O'Callaghan, P Sen, A Nune, ... Muscle & nerve 66 (4), 426-437, 2022 | 34 | 2022 |
| The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study M Sloan, C Gordon, R Harwood, E Lever, C Wincup, M Bosley, ... Rheumatology advances in practice 5 (1), rkaa072, 2021 | 33 | 2021 |
| The differences between childhood and adult onset antiphospholipid syndrome C Wincup, Y Ioannou Frontiers in pediatrics 6, 362, 2018 | 32 | 2018 |
| Increased apolipoprotein-B: A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE GA Robinson, KE Waddington, L Coelewij, J Peng, M Naja, C Wincup, ... EBioMedicine 65, 2021 | 29 | 2021 |
| Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus C Wincup, N Sawford, A Rahman Expert review of clinical immunology 17 (9), 957-967, 2021 | 26 | 2021 |
| Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies MGL Wilkinson, A Radziszewska, C Wincup, Y Ioannou, DA Isenberg, ... Rheumatology 59 (1), 194-204, 2020 | 22 | 2020 |
| Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort BT Segura, I Rua-Figueroa, JM Pego-Reigosa, V Del Campo, C Wincup, ... BMJ open 9 (6), e028697, 2019 | 19 | 2019 |
| The role of immunometabolism in the pathogenesis of systemic lupus erythematosus GA Robinson, MGL Wilkinson, C Wincup Frontiers in Immunology 12, 806560, 2022 | 18 | 2022 |
| COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis R Naveen, I Parodis, M Joshi, P Sen, J Lindblom, V Agarwal, JB Lilleker, ... Rheumatology 62 (7), 2366-2376, 2023 | 17 | 2023 |
| Antiphospholipid antibodies to domain I of beta-2-glycoprotein I show different subclass predominance in comparison to antibodies to whole beta-2-glycoprotein I T McDonnell, B Artim-Esen, C Wincup, VM Ripoll, D Isenberg, IP Giles, ... Frontiers in immunology 9, 2244, 2018 | 17 | 2018 |
| Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets HF Bradford, L Haljasmägi, M Menon, TCR McDonnell, K Särekannu, ... Cell Reports Medicine 4 (1), 2023 | 16 | 2023 |
